节点文献

卵巢交界性肿瘤复发相关因素临床特点及处理原则

Recurrence of borderline ovarian tumor:the related factors,clinical characteristics and management strategy

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 陈英汉王丹波

【Author】 CHEN Ying-han;WANG Dan-bo;Department of Obstetrics and Gynecology,Shengjing Hospital of China Medical University;

【机构】 中国医科大学附属盛京医院妇产科

【摘要】 卵巢交界性肿瘤总体复发率为11%。复发的不良因素主要包括:进展期、浸润性种植、病灶残留。保守性手术的复发率高,但大部分复发仍为交界性,且局限于卵巢内,不影响生存率。对于卵巢内复发,渴望保留生育功能的年轻患者,如没有浸润性种植并可接受长期严密随访,可再次行保守性手术。如果存在浸润性种植、卵巢外复发或进展为恶性卵巢癌,应行肿瘤细胞减灭术。目前没有证据表明术后化疗对于复发性交界性肿瘤有益。

【Abstract】 The overall recurrence rate for borderline ovarian tumors is estimated to be 11%. Major negative prognostic factors for recurrence are more advanced disease, the presence of invasive implants and/or the presence of postoperative macroscopic residual disease. The rate of recurrence is higher after conservative surgery. Most of these recurrences are borderline type and are found on the spared ovary with an excellent long-term survival. If a relapse in the remaining ovary occurs without invasive implants, further conservative management may be offered to patients who are young, desire fertility preservation, and engage in long-term follow-up. When extraovarian recurrence, invasive implants or invasive disease occur, extensive cytoreductive surgery is the treatment option of choice. To date, there is no proven benefit from adjuvant chemotherapy.

【关键词】 卵巢交界性肿瘤复发处理
【Key words】 borderline ovarian tumorrecurrencemanagement
  • 【文献出处】 中国实用妇科与产科杂志 ,Chinese Journal of Practical Gynecology and Obstetrics , 编辑部邮箱 ,2015年11期
  • 【分类号】R737.31
  • 【被引频次】9
  • 【下载频次】456
节点文献中: 

本文链接的文献网络图示:

本文的引文网络